Results 141 to 150 of about 21,823 (309)

The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis [PDF]

The development and progression of ascites represent a crucial event in the natural history of patients with cirrhosis, predisposing them to other complications and carrying a heavy impact on prognosis.
Baldassarre, Maurizio, Caraceni, Paolo, De Venuto, Clara, Iannone, Giulia, Pompili, Enrico, Pratelli, Dario, Tedesco, Greta, Zaccherini, Giacomo   +7 more
core   +1 more source

Sustained Bacteremia Associated with Transjugular Intrahepatic Portosystemic Shunt (TIPS) [PDF]

, 2000
Joseph DeSimone, Kathleen G. Beavis, David J. Eschelman, K J Henning   +3 more
openalex   +1 more source

A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites [PDF]

, 2000
Martin Rössle, Andreas Ochs, Veit Gülberg, V. Siegerstetter, Joseph Holl, Peter Deibert, Manfred Olschewski, Maximilian F. Reiser, Alexander L. Gerbes   +8 more
openalex   +1 more source

Transjugular antegrade transvenous obliteration, with and without portal decompression, for management of rectal variceal hemorrhage

CVIR Endovascular
Purpose To report antegrade transvenous obliteration, with or without concurrent portosystemic shunt creation, for the treatment of hemorrhagic rectal varices.
Gabriel E. Li, Jeffrey Forris Beecham Chick, Eric J. Monroe, Matthew Abad-Santos, Ethan W. Hua, David S. Shin   +5 more
doaj   +1 more source

Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy

Journal of Clinical Interventional Radiology ISVIR
Purpose Transjugular intrahepatic portosystemic shunt (TIPS) is an established intervention for symptomatic portal hypertension, with many patients experiencing hepatic encephalopathy (HE) as an undesirable side effect.
Brandon Toliver, Matthew Thornburg, Adam Schmitz, Paul Haste   +3 more
doaj   +1 more source

Shunt dysfunction patterns after transjugular intrahepatic portosystemic shunt creation using a combination of a generic stent-graft and bare-stents. [PDF]

Even though transjugular intrahepatic portosystemic shunt (TIPS) using Fluency Stent-grafts provides good shunt patency rates, shunt dysfunction is a great concern after TIPS creation, occurring in up to 20% of cases within one year.
Artru, F., Denys, A., Duran, R., Gonzalez-Quevedo, M., Gravel, G., Tsoumakidou, G., Villard, N.   +6 more
core   +1 more source

We are all trying to predict what we don’t know!

Annals of Hepatology, 2013
The current issue of Annals of Hepatology has multiple articles trying to predict different aspects of liver disease: steatohepatitis in non-alcoholic fatty liver disease (NAFLD), steatosis and fibrosis in hepatitis C virus (HCV) infected patients ...
Kevork M. Peltekian
doaj  

Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting [PDF]

, 2000
Naga Chalasani, W.Scott Clark, L G Martin, Jeffrie Kamean, Mehran Ali Khan, Nilesh H. Patel, Thomas Boyer   +6 more
openalex   +1 more source

Clinical Results of the Transjugular Intrahepatic Portosystemic Shunt TIPS for the Treatment of Variceal Bleeding [PDF]

, 2000
Sang Woo Han, Young‐Eun Joo, Hyun‐Soo Kim, Sung Kyu Choi, Jong Sun Rew, Jae Kyu Kim, Sei Jong Kim   +6 more
openalex   +1 more source

Transjugular intrahepatic portosystemic shunt for intractable colonic bleeding in a patient with cirrhosis [PDF]

, 2000
Sina A. Malki, Robert J. Allen, Paul Pavli   +2 more
openalex   +1 more source